home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

RNA And Tumour Suppression

  January, 24 2008 9:02
your information resource in human molecular genetics

Deletions on chromosome 5q are associated with certain blood-cell-production diseases and in Nature researchers identify a candidate tumour suppressor gene for these.

Using an RNA-interference-based approach to identify haploinsufficient tumour suppressor genes, Todd R. Golub and colleagues identify a molecule called RPS14. It usually acts as a regulator of ribosomal RNA processing and the research adds to the growing list of ribosomal factors that are linked to tumour suppression when they are not expressed properly. Forced expression of RPS14 in patient-derived bone marrow cells rescued the disease phenotype. The research demonstrates that RNAi screening is an effective strategy for identifying genes for haploinsufficient disorders ? which occur when only a single copy of a gene is functional.


Todd R. Golub (Broad Institute of Harvard and MIT, Cambridge, MA, USA)
E-mail: golub@broad.harvard.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.